Neonatal invasive candidiasis;Candidiasi sistemiche neonatali

Minerva Pediatrica

Volumn 58, Issue 6, 2006, Pages 537-549

  Stronati, M ^a   Decembrino, L ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b NONE

Author keywords

Candidiasis; Fungi; Infant, newborn

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; MICAFUNGIN; MICONAZOLE; NYSTATIN; PLACEBO; PNEUMOCANDIN DERIVATIVE; TERBINAFINE; VORICONAZOLE;

ABSENCE OF SIDE EFFECTS; CANDIDA ALBICANS; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG POTENTIATION; FUNGUS TRANSMISSION; HIGH RISK POPULATION; HUMAN; HYPOKALEMIA; INFECTION RISK; INVASIVE CANDIDIASIS; MONOTHERAPY; MORTALITY; MYCOSIS; NEPHROTOXICITY; NEWBORN DISEASE; PROGNOSIS; REVIEW; VERY LOW BIRTH WEIGHT;

AGE FACTORS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDIASIS; DRUG THERAPY, COMBINATION; FLUCONAZOLE; FLUCYTOSINE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; PROGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33846518346     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:63-71.
2. Moro ML, Stolfi I, Di Lella O, Sbaraglia T. Epidemiologia delle infezioni nei reparti di TIN. Studio multicentrico. Aggiornamenti in Neonatologia 1996;4:1-2.
3. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factor and predictors of mortality. Clin Infect Dis 1992;15:414-21.
4. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998;17:504-8.
5. Padovani EM, Michielutti F, Dall'Agnola A, Dal Moro A, Khoory BJ. [Sepsis caused by Candida in the neonatal period] Pediatr Med Chir 1997;19:83-8. Italian.
6. Mittal M, Dhanireddy R, Higgins RD. Candida sepsis and associations with retinopathy of prematurity. Pediatrics 1998;101 (4 Pt 1):654-7.
7. Walsh TJ, Gonzales C, Lyman CA, Chanock SJ, Pizzo PA. Invasive fungal infections in children: recent advances in diagnosis and treatment. Adv Pediatr Infect Dis 1996;11:187-290.
8. Rabalais GP, Samiec TD, Bryant KK, Lewis JJ. Invasive candidiasis in infants weighting more than 2500 grams at birth admitted to a neonatal intensive care unit. Pediatr Infect Dis J 1996;15:348-52.
9. Butler KM, Baker CJ. Candida: an increasingly important pathogen in the nursery. Pediatr Clin North Am 1988;35:543-63.
10. Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low birth weight infants: clinical manifestations and epidemiology. Pediatrics 1984;73:144-52.
11. Johnson DE, Thompson TR, Green TP, Ferrieri P. Systemic candidiasis in very low-birth-weight infants (<1500 grams). Pediatrics 1984;73:138-43.
12. McDonnell M. Fungal infections in the newborn. Semin Neonatol 1996;1:141.
13. Baley JE. Neonatal candidiasis: the current challenge. Clin Perinatol 1991;18:263-80.
14. Sanchez PJ. Miscellaneus infections of the newborn. In: Feigin RD, Cherry JD editors. Texbook of pediatric infectious diseases. Philadelphia: W.B. Saunders Company; 1998. p. 926.
15. McDonnel M, Isaacs D. Neonatal systemic candidiasis. J Paediatr Child Health 1995;31:490-2.
16. Ng PC. Systemic fungal infections in neonates. Arch Dis Child 1994;71:F130-5.
17. Remington JS, Klein JO. Infectious diseases of the fetus newborn infant. 4th ed. Philadelphia: W.B. Saunders Company; 1995.
18. Waggoner-Fountain L, Walker MW, Hollis RJ, Pfaller MA, Ferguson JE 2nd, Wenzel RP et al. Vertical and horizontal transmission of unique Candida species to premature newborns. Clin Infect Dis 1996;22:803-8.
19. Reef SE, Lasker BA, Butcher DS, McNeil MM, Pruitt R, Keyserling H et al. Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study. J Clin Microbiol 1998;36:1255-9.
20. Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J et al. Risk factor for candidemia in Neonatal Intensive Care Unit. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J 2000;19:319-24.
21. Baley JE, Kliegman RM, Boxerbaum F, Fanaroff AA. Fungal colonization in the very low birth weight infant. Pediatrics 1986;78:225-32.
22. Huang YC, Li CC, Lin TY, Lien RI, Chou YH, Wu JL et al. Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect Dis J 1998;17:819-22.
23. Rowen JL, Rench MA, Kozinetz CA, Adams JM Jr, Baker CJ. Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates. J Pediatr 1994;124 (5 Pt 1):789-94.
24. El-Mohandes AE, Johnson-Robbins L, Keiser JF, Simmens SJ, Aure MV. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease. Pediatr Infect Dis J 1994;13:520-4.
25. Shattuck KE, Cochran CK, Zabransky RJ, Pasarell L, Davis JC, Malloy MH. Colonization and infection associated with Malassenzia and Candida species in a Neonatal Unit. J Hosp Infect 1996;34:123-9.
26. Botas MC, Kurlat I, Young SM, Sola A. Disseminated candidal infections and intravenous Hydrocortisone in preterm infants. Pediatrics 1995;95:883-7.
27. Lombardi G, Stronati M, Michelone G, Cavanna C, Rondini G. [Neonatal systemic infections caused by Candida albicans] Minerva Pediatr 1986;38:963-8. Italian.
28. Narang A, Agawal PB, Chakrabarti A, Kumar P. Epidemiology of systemic candidiasis in a tertiary care neonatal unit. J Tropical Pediatrics 1998;44:104-8.
29. Jeffries I, Soler M, Schwartz M et al. Fungal infections in the neonatal intensive care unit. Int Pediatr 1997;12:133.
30. Melville C, Kempley S, Graham J, Berry CL. Early onset systemic Candida infection in extremely preterm neonates. Eur J Pediatr 1996;155:904-6.
31. Bale JF, Murph JR. Infections of the central nervous system in the newborn. Clin Perinatol 1997;24:787-807.
32. Benjamin DK Jr, Fisher RG, McKinney RE Jr, Benjamin DK. Candidal mycetoma in the neonatal kidney. Pediatrics 1999;104:1126-9.
33. Miller MJ. Fungal infections. In: Remington JS, Klein JO editors. Infectious disease of the fetus, newborn and infant. 4th ed. Philadelphia: WB Sanders; 1995. p. 704-36.
34. Stuck KJ, Silver TM, Jaffe MH, Bowerman RA. Sonographic demonstration of renal fungus balls. Radiology 1981;142:473-4.
35. Mogyorosy G, Soos G, Nagy A. Candida endocarditis in a premature infant. J Perinat Med 2000;28:407-11.
36. Mayayo E, Moralejo J, Camps J, Guarro J. Fungal endocarditis in a premature infants: case report and review. Clin Infect Dis 1996;22:366-8.
37. Daftary SK, Patole JS, White Hall. Intracardiac fungal masses in high risk neonates. Clinical observation. Pediatrics 1999;88:1009-13.
38. Sanchez PJ, Siegel JD, Fishbein J. Candida endocarditis. successful medical management in three preterm infants and review of literature. Pediatr J Infect Dis 1991;10:239-43.
39. Vaideeswar P, Sivaraman A, Deshpande JR. Neonatal candidial endocarditis: a rare manifestation of systemic candidiasis. Indian J Pathol Microbiol 1999;42:165-8.
40. Alkalay A, Mazkereth R, Santulli T, Pomerance JJ. Central venous line thrombosis in premature infants: a case management and literature review. Am J Perinatol 1993;10:323-6.
41. Peters M, Ten Cate JW, Koo Lh, Breederveld. Persistent antithrombin II deficiency. Risk factor for thromboembolic complications in neonates small for gestational age. J Pediatr 1984;105:310-4.
42. Ozkutlu S, Ozbarlas N, Ozme S, Saraclar M, Gogus S, Demircin M. Intracardiac thrombosis diagnosed by echocardiography in childhood: predisposing and etiological factors. Int J Cardiol 1993;40:251-6.
43. Smith SD, Tagge EP, Miller J, Cheu H, Sukarochana K, Rowe MI. The hidden mortality in surgically treated necrotizing enterocolitis fungal sepsis. J Pediatr Surg 1990;25:1030-3.
44. Swanson H, Hughes PA, Messer SA, Lepow ML, Pfaller MA. Candida Albicans arthritis one year after successfull treatment of fungemia in a healty infant. J Pediatr 1996;129:688-94.
45. Baley JE, Annable WL, Kliegman RM. Candida endophtalmitis in the premature infant. J Pediatr 1981;98:458-6l.
46. Chen JY. Neonatal candidiasis associated with meningitis and endophtalmitis. Acta Paediatr Jpn 1994;36:261-5.
47. Jill E, Forrest JE. Neonatal candidiasis: oftalmologic infection. Semin Perinatol 2003;27:401-5.
48. Noyola DE, Boha L, Paysse EA, Fernandez M, Coats DK. Association of candidemia and retinopathy of prematurity in very low birthweight infants. Ophtalmology 2002;109:80-4.
49. Ashman RB, Papadinitriou JM. Endothelial cell proliferation associated with lesions of murine systemic candidiasis. Infect Immunol 1994;62:5151-3.
50. Reddy TCS, Chakrabarti A, Singh M, Singhi. Role of buffy coat examination in the diagnosis of neonatal candidemia. Pediatr Infect Dis J 1996;15:718-20.
51. André N, Millet V, Bartoli JM, Lacroze V, Unal D. [Congenital candidiasis: early diagnosis and treatment with fluconazole] Arch Pediatr 1997;4:903. French.
52. Contreras I, San-Millán R, Agustín-Barrasa A, Ponton J, Quindos G. Utility of albicans ID plate for rapid identification of Candida albicans in clinical sample. Mycopathologia 1996;136:17-20.
53. Rowen JL, Tate JM. Management of neonatal candidiasis. Pediatr Infect Dis J 1998;17:1007-11.
54. Kingo AR, Smyth JA, Waisman D. Lack of evidence of amphotericin B toxicity in very low birth weight infants treated for systemic candidiasis. Pediatr Infect Dis J 1997;16:1002-3.
55. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000;30:662-78.
56. Chapman RL. Candida infections in the neonate. Curr Opin Pediatr 2003;15:97-102.
57. Huang YC, Hsiu-Tsun Kao, Tzou-Yen Lin, Kuo AJ. Antifungal susceptibilty testing and the correlation with clinical outcome in neonatal candidemia. Am J Perinatol 2001;18:141-6.
58. Fasano C, O'Keeffe J, Gibbs D. Fluconazole treatment of neonates and infants with severe fungal infections not treatable with conventional agents. Eur J Clin Microbiol Infect Dis 1994;13:351-4.
59. Bilgen H, Ozek E, Korten V, Ener B, Molbay D. Treatment of systemic neonatal candidiasis with fluconazole. Infection 1995;23:394.
60. Driessen M, Ellis JB, Cooper PA, Wainer S, Muwazi F, Hahn D et al. Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. Pediatr Infect Dis J 1996;15:1107-12.
61. Gurpinar AN, Balkan E, Kilic N, Kiristioglu I, Avsar I, Dogruyol H. Fluconazole treatment of neonates and infants with severe fungal infections. J Int Med Res 1997;25:214-8.
62. Wainer S, Cooper PA, Gouws H, Akierman A. A prospective study of fluconazole therapy in systemic neonatal fungal infection. Pediatr Infect Dis J 1997;16:763-7.
63. Wenzl TG, Schefels J, Hornchen H, Skopnik H. Pharmacokinetics of oral fluconazole in premature infants. Eur J Pediatr 1998;157:661-2.
64. Huttova M, Hartmanova I, Kralinsky K, Filka J, Uher J, Kurak J et al. Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. Pediatr Infect Dis J 1998;17:1012-5.
65. Graybill JR. The future of antifungal therapy. Clin Infect Dis 1996;22 (2 Suppl):S166-78.
66. Hiemenz JW, Walsh TJ. Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis 1996;22 Suppl 2:S133-44.
67. Lackner H, Schwinger W, Urban C, Muller W, Ritschel E, Reiterer F et al. Liposomal amphotericin-B (AmBisome(r)) for treatment of disseminated fungal infections in two infants of very low birth weight. Pediatrics 1992;89(6 Pt 2):1259-6l.
68. Jarløv JO, Born P, Bruun B. Candida albicans meningitis in a 27 weeks premature infant treated with liposomal amphotericin-B (AmBisome(r)). Scand J Infect Dis 1995;27:419-20.
69. Al Arishi H, Frayha HH, Kalloghlian A, al Alaiyan S. Liposomal amphotericin B in neonates with invasive candidiasis. Am J Perinatol 1997;14:573-6.
70. Evdoridou J, Roilides E, Bibashi E, Kremenopoulos G. Multifocal osteoarthritis due to Candida albicans in a neonate: serum level monitoring of liposomal amphotericin B and literature review. Infection 1997;25:112-6.
71. Scarcella A, Pasquariello MB, Giugliano B, Vendemmia M, de Lucia A. Liposomal amphotericin B treatment neonatal fungal infections. Pediatr Infect Dis J 1998;17:146-8.
72. Weitkamp JH, Poets CF, Sievers R, Musswessels E, Groneck P, Thomas P et al. Candida infection in very low birth-weight infants: outcome and nephrotoxicity of treatment with liposomal amphotericin B (AmBisome(r)). Infection 1998;26:11-5.
73. Bangham AD. Liposomes: realizing their promise. Hosp Pract (Off Ed) 1992;27:51-6, 61-2.
74. Ostro MJ, Cullis PR. Use of liposomes as injectable-drug delivery systems. Am J Hosp Pharm 1989;46:1576-87.
75. Moreau P, Milpied N, Fayette N, Ramee JF, Harousseau JL. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with conventional amphotericin B in neutropenic patients. J Antimicrob Chemoter 1992;30:535-41.
76. Friedlich PS, Steinberg I, Fujitani A, deLemos RA. Renal tolerance with the use of intralipid-amphotericin B in low-birth-weight neonates. Am J Perinatol 1997;14:377-83.
77. Trissel LA. Amphotericin B does not mix with fat emulsion. Am J Health Syst Pharm 1995;52:1463-64.
78. Walsh TJ, Seibel NL, Arndt C, Harris RE, Dinubile MJ, Reboli A et al. Amphotericin B lipid complex in pediatric patients with invasive fungal infections. Pediatr infect Dis J 1999;18:702-8.
79. Adler-Shohet F, Waskin H, Lieberman JM. Amphotericin B lipid complex for neonatal invasive candidiasis. Arch Dis Child Fetal Neonatal Ed 2001;84:F131-3.
80. Huang YC, Lin TY, Peng HL, Wu JH, Chang HY, Leu HS. Outbreak of Candida albicans fungaemia in a neonatal intensive care unit. Scand J Infect Dis 1998;30:137-42.
81. Pfaller MA, Diekema DJ, Jones RN, Messer SA, Hollis RJ; SENTRY Participants Group. Trends in antifungal susceptibility of candidiasis isolated from pediatric and adult patients with bloodsteam infections: SENTRY antimicrobila surveillance program 1997 to 2000. J Clin Microbiol 2002;40:852-6.
82. Demuri GP, Hostetter MK. Resistance to antifungal agents. Pediatr Clin North Am 1995;42:665-84.
83. Nguyen MH, Peacock JE, Morris AJ, Tanner DC, Nguyen ML, Snydman DR et al. The changing face of candidemia: emergence of non Candida albicans species and antifungal resistance. Am J Med 1996;100:617-23.
84. Brammer KW, Coates PE. Pharmacokinetes of fluconazole in pediatric patients. Eur J Clin Microbiol Infect Dis 1994;13:325-9.
85. Bliss JM, Wellington M., Gigliotti F. Antifungal pharmacotherapy for neonatal candidiasis. Semin Perinatol 2003;27:365-74.
86. Arathoon EG. Clinical efficacy of echinocandin antifungals. Curr Opin Infect Dis 2001;14:685-91.
87. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J et al. Comparison of caspofungin and amphotericin. N Engl J Med 2002;347:2020-9.
88. Walsh TJ, Adamson PC, Seibel NL, Flynn PM, Neely MN, MilleR A et al. Pharmacokinetics of caspofungin in pediatric patients. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, 2002, September 27-30, San Diego, CA.
89. Patterson TF. Combination antifungal therapy. Pediatr Infect Dis J 2003;22:555-6.
90. Perea S, Gonzalez G, Fothergill AW, Sutton DA, Rinaldi MG. In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles. J Clin Microbiol 2002;40:1831-3.
91. Bachman SP, Ramage G, VandeWalle K, Patterson TF, Wickes BL, Lopez-Ribot JL. Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob Agents Chemother 2003;47:3657-9.
92. Faix R. Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatr Infect Dis J 1992;11:88-93.
93. Kaufman D. Strategies for prevention of neonatal invasive candidiasis. Semin Perinatol 2003;27:414-24.
94. Seeling MS, Kozinn PJ. Clinical manifestation and management of candidodsis in the compromised patient. In: Warnock DW, Richardson MD editors. Fungal infections in the compromised patient. New York: John Wiley e Sons; 1982. p. 49.
95. Sims ME, You H, You H, Salminen C, Walther FJ. Prophylactic oral nystatin and fungal infections in very low birth weight infants. Am J Perinatol 1988;5:33-6.
96. Wainer S, Cooper PA, Funk E, Bental RY, Sandler DA, Patel J. Prophylactic miconazole oral gel for the prevention of neonatal fungal rectal colonization and systemic infection. Pediatr Infect Dis J 1992;11:713-6.
97. Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001;107:293-8.
98. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001;345:1660-6.